Prevalence and predictors of airflow obstruction in an <scp>HIV</scp> tertiary care clinic in Montreal, Canada: a cross‐sectional study

Abstract

Objectives The reported prevalence of chronic obstructive pulmonary disease ( COPD ) in people living with HIV ( PLWHIV ) varies widely. Our objective was to estimate the prevalence of airflow obstruction and COPD in unselected PLWHIV and identify characteristics that increase the risk of nonreversible airflow obstruction in order to guide case finding strategies for COPD . Methods All adults attending the Chronic Viral Illness Service were invited to participate in the study, regardless of smoking status or history of known COPD /asthma. Individuals underwent spirometric testing both before and after use of a salbutamol bronchodilator. Airflow obstruction was defined as forced expiratory volume in 1 s ( FEV 1 )/forced vital capacity ( FVC ) &lt; 0.7 post‐bronchodilation, whereas COPD was defined as FEV 1 / FVC &lt; 0.7 post‐bronchodilation and Medical Research Council ( MRC ) score &gt; 2. Multivariate logistic regression was used to evaluate risk factors associated with airflow obstruction, reported as adjusted odds ratios ( aORs ). Results Five hundred and three participants successfully completed spirometry testing. The median (Q1; Q3) age was 52 (44; 58) years. The median (Q1; Q3) CD 4 count was 598 (438; 784) cells/μL and the median (Q1; Q3) nadir CD 4 count was 224 (121; 351) cells/μL. There were 119 (24%) current smokers and 145 (29%) former smokers. Among those screened, 54 (11%) had airflow obstruction whereas three (1%) of the participants had COPD . Factors that were associated with airflow obstruction included a history of smoking [ aOR 2.2; 95% confidence interval ( CI ) 1.1; 4.7], older age (aOR 1.6; 95% CI 1.2; 2.2), and lower CD 4 count (aOR 0.8; 95% CI 0.7; 1.0). Conclusions Airflow obstruction was relatively uncommon. Our findings suggest that PLWHIV who are ≥50 years old, smokers and those with nadir CD 4 counts ≤ 200 cells/μL could be targeted to undergo spirometry to diagnose chronic airflow obstruction.